GLAND PHARMA
Back to Cashflow Statement
|
GLAND PHARMA Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹1,031 Cr | ₹915 Cr | ₹997 Cr | ₹364 Cr | ₹791 Cr |
What is the latest Cash Flow from Operating Activities ratio of GLAND PHARMA ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹1,031 Cr |
| Mar2025 | ₹915 Cr |
| Mar2024 | ₹997 Cr |
| Mar2023 | ₹364 Cr |
| Mar2022 | ₹791 Cr |
How is Cash Flow from Operating Activities of GLAND PHARMA Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,031 Cr | 12.75 | |
| Mar2025 | ₹915 Cr | -8.23 | |
| Mar2024 | ₹997 Cr | 173.87 | |
| Mar2023 | ₹364 Cr | -53.97 | |
| Mar2022 | ₹791 Cr | - | |
Compare Cash Flow from Operating Activities of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹54,573.8 Cr | 4.4% | 7.1% | 75.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹452,707.0 Cr | 1.4% | 6.7% | 12% | Stock Analytics | |
| DIVIS LABORATORIES | ₹303,962.0 Cr | 11.1% | 23.5% | 70% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,494.0 Cr | 1% | 1.8% | 34.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,769.0 Cr | 1.1% | 11.8% | 14.2% | Stock Analytics | |
| CIPLA | ₹113,912.0 Cr | 0.1% | 6% | -5.8% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | 4.4% |
7.1% |
75.2% |
| SENSEX | 3.3% |
13.9% |
-1.7% |
You may also like the below Video Courses